Femme Homme
- | Pays :
- Belgium
- Switzerland
- Sweden
- ...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to assess the activity of XRP9881 in combination with trastuzumab. The secondary objectives are safety and pharmacokinetic interaction
Critère d'inclusion
- Breast Neoplasms